Clinical Trial Update: A Study of Avutometinib + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer in Japanese Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Avutometinib plus Defactinib in Japanese patients with recurrent low-grade serous ovarian cancer; the study is currently activ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low-grade Serous Ovarian Cancer
• Ovarian Cancer

Drugs mentioned

• Avutometinib (avutometinib)
• Defactinib (defactinib)

Snippet

Sponsor: Verastem, Inc. | Conditions: Low Grade Serous Ovarian Cancer, Ovarian Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING